CLINICAL_TRIALS
trial_result
· 2020-12-24
Clinical Trial Update: Afatinib Osimertinib Sequencing NIS
Summary
A completed clinical trial evaluating sequencing of afatinib and osimertinib in non-small cell lung carcinoma; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Carcinoma, Non-Small-Cell Lung | Status: COMPLETED | Results posted: 2020-12-24